Factors associated with successful phase III trials for solid tumors: A systematic review

par Yasushi Otsuka, Masayuki Kaneko, Mamoru Narukawa
Publié 2021

Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov

par Kentaro Sakamaki, Yukari Uemura, Yosuke Shimizu
Publié 2021

Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis

par Yanhong Yao, Yanhong Yao, Zhentao Liu, Hua Zhang, Jian Li, Zhi Peng, Jinyu Yu, Baoshan Cao, Lin Shen
Publié 2021

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes

par Marina Vladimirovna Shestakova, Michail Vladimirovich Antciferov, Alexander Yur'evich Mayorov, Luydmila Alexandrovna Ruyatkina, Ludmila Alexandrovna Suplotova, Sergey Anatol'evich Dogadin, Nikolay Borisovich Lebedev, Yana Gennadievna Alekseeva
Publié 2015